Long-acting growth hormone subcutaneous injection (somatrogon-ghla): price analysis and purchasing channels

Long-acting subcutaneous injection of growth hormone (Somatrogon-ghla) is a drug specially used to treat growth disorders caused by insufficient secretion of endogenous growth hormone, especially for children aged 3 years and above. The drug provides an effective treatment option for children with growth hormone deficiency by simulating the growth hormone naturally secreted by the human body.

As a long-acting formulation, Somatrogon-ghla is unique in that it can significantly reduce the patient's injection frequency from traditional daily injections to once a week, thereby greatly improving patients' medication compliance and quality of life. This drug is administered by subcutaneous injection. The injection site is usually selected in the abdomen, thigh, buttocks or upper arm, and needs to be rotated regularly to ensure uniform absorption of the drug and reduce the occurrence of local adverse reactions.

In clinical application,Somatrogon-ghla has shown significant efficacy. It can help patients achieve normal height growth and improve growth retardation caused by growth hormone deficiency. At the same time, the safety of the drug has also been widely recognized, and common adverse reactions are usually mild and have a low incidence rate.

With the gradual promotion and application of Somatrogon-ghla around the world, more and more patients with growth hormone deficiency will benefit from this innovative drug. It not only provides patients with new treatment options, but also provides doctors and medical workers with more convenient and effective treatment methods, further promoting the development of the field of growth hormone deficiency treatment.

Currently, long-acting growth hormone subcutaneous injection has not been launched in the domestic market, so domestic patients cannot directly purchase this drug for the time being. However, as far as we know, the drug has been launched overseas, and its price is about 13,000 yuan per vial.

Reference: https://www.drugs.com/monograph/somatrogon-ghla.html